Lupus Erythematosus, Systemic: all 1,222 studies

Page 5 of 13. Open to participants first (399), then studies with results posted, then the rest; newest registration first within each.

• A Study of Belimumab in Chinese Pediatric Participants With Systemic Lupus ErythematosusCompletedNCT05917288Phase 1Results posted
• A Study to Learn About the Study Medicine (PF-06823859) in Adults With Active CLE or SLE With Skin Symptoms.TerminatedNCT05879718Phase 2Results posted
• A Study of Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis (PALIZADE)TerminatedNCT05781750Phase 2Results posted
• A Study of DS-7011a in Patients With Systemic Lupus ErythematosusCompletedNCT05638802Phase 1/2Results posted
• Study of Daxdilimab (HZN-7734) for the Treatment of Systemic Lupus Erythematosus in an Open-label Extension StudyTerminatedNCT05430854Phase 2Results posted
• Utilizing Qualitative and Quantitative Methods to Understand a New Model of Type 1 and 2 Systemic Lupus Erythematosus (SLE)CompletedNCT05426902Not applicableResults posted
• Examining Distinct Immunophenotypes to Validate and Enhance Rational Treatment in Systemic LupusTerminatedNCT05306873Phase 2Results posted
• Phone-Based Based Walk With Ease Program for Adults With ArthritisCompletedNCT05289544Not applicableResults posted
• The WILLOW Study With M5049 in SLE and CLE (SCLE and/or DLE) (WILLOW)CompletedNCT05162586Phase 2Results posted
• A IMMA Master Protocol: A Study of LY3361237 in Participants With at Least Moderately Active Systemic Lupus ErythematosusTerminatedNCT05123586Phase 2Results posted
• Breaking Implicit Bias Habits: An Individuation Pilot Study In RheumatologyCompletedNCT05116163Not applicableResults posted
• PRV-3279-2a Trial in Systemic LupusTerminatedNCT05087628Phase 2Results posted
• Evaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLECompletedNCT05001737Phase 3Results posted
• COVID-19 Booster Vaccine in Autoimmune Disease Non-RespondersTerminatedNCT05000216Phase 2Results posted
• Study to Assess Demographic, Pharmacologic, Biomarker, Clinical Features and Quality of Life (QoL) of Participants With Lupus NephritisCompletedNCT04971590Results posted
• Study of VIB7734 for the Treatment of Moderate to Severely Active SLECompletedNCT04925934Phase 2Results posted
• Open-label Study of Belimumab Plus Standard Therapy in Chinese Pediatric Participants With Active Systemic Lupus Erythematosus (SLE)CompletedNCT04908865Phase 4Results posted
• Study of Ruxolitinib Cream for the Treatment of Discoid Lupus ErythematosusCompletedNCT04908280Phase 2Results posted
• ALPN-101 (Acazicolcept) in Systemic Lupus ErythematosusCompletedNCT04835441Phase 2Results posted
• Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE)TerminatedNCT04809623Phase 1Results posted
• Medication Adherence Patterns in Rheumatic Diseases: A Behavioral TrialCompletedNCT04776161Not applicableResults posted
• Efficacy and Safety of Efavaleukin Alfa in Subjects With Active Systemic Lupus ErythematosusTerminatedNCT04680637Phase 2Results posted
• CCCR Lupus Patient Navigator ProgramCompletedNCT04461158Not applicableResults posted
• A Study of the Safety of Oral Elsubrutinib Capsules and Oral Upadacitinib Tablets Given Alone or in Combination (ABBV-599) for Adult Participants With Moderately to Severely Active Systemic Lupus Erythematosus to Assess Change in Disease StateCompletedNCT04451772Phase 2Results posted
• A Study of LY3471851 in Adults With Systemic Lupus Erythematosus (SLE)CompletedNCT04433585Phase 2Results posted
• A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus ErythematosusCompletedNCT04294667Phase 3Results posted
• Genomic Effects of Glucocorticoids in Patients With Systemic Lupus ErythematosusCompletedNCT04233164Early Phase 1Results posted
• Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid ArthritisCompletedNCT04186871Phase 2Results posted
• Study of Subcutaneous (SC) Belimumab in Pediatric Participants With Systemic Lupus Erythematosus (SLE)Active, not recruitingNCT04179032Phase 2Results posted
• LUPUS Brain: tACS to Target the Neurophysiology of Depression, Cognitive Deficits, and Pain in Patients With SLETerminatedNCT04141046Not applicableResults posted
• Single Dose Study to Investigate the Pharmacokinetics (PK) and Safety of Belimumab 200 Milligrams (mg) Intravenous and 200 mg Subcutaneous Via Auto-injector in Chinese Healthy SubjectsCompletedNCT04136145Phase 1Results posted
• Study of EQ001 (Itolizumab) in Systemic Lupus Erythematosus With or Without Active Proliferative NephritisCompletedNCT04128579Phase 1Results posted
• Efficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE)CompletedNCT04058028Phase 2Results posted
• A Study to Investigate the Safety and Efficacy of Elsubrutinib and Upadacitinib Given Alone or in Combination in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE)CompletedNCT03978520Phase 2Results posted
• Efficacy and Safety of Delgocitinib Cream in Discoid Lupus Erythematosus.TerminatedNCT03958955Phase 2Results posted
• Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic ConditionsCompletedNCT03938324Not applicableResults posted
• Long-Term Safety and Efficacy Study of Deucravacitinib in Participants With Systemic Lupus ErythematosusCompletedNCT03920267Phase 2Results posted
• Addressing Disparities in Lupus Care Through an Integrated Care Management ProgramCompletedNCT03915652Not applicableResults posted
• A DOSE-RANGING STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-06700841 IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)CompletedNCT03845517Phase 2Results posted
• A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE)TerminatedNCT03843125Phase 3Results posted
• Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus ErythematosusCompletedNCT03742037Phase 2Results posted
• Reducing Disparities in Medication Adherence in SLECompletedNCT03738826Not applicableResults posted
• Implementing the Decision-Aid for Lupus (IDEAL Strategy)CompletedNCT03735238Results posted
• Peer Approaches to Lupus Self-managementActive, not recruitingNCT03734055Not applicableResults posted
• A Study to Evaluate the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of TAK-079 in Combination With Standard Background Therapy in Participants With Moderate to Severe Systemic Lupus Erythematosus (SLE)CompletedNCT03724916Phase 1Results posted
• Study the Efficacy and Safety of VAY736 and CFZ533 in SLE PatientsCompletedNCT03656562Phase 2Results posted
• Evaluating HIV-1 Neutralization Antibody Breadth in Response to HIV gp120 Protein Vaccine in HIV-uninfected Adults With Quiescent Systemic Lupus ErythematosusCompletedNCT03618056Phase 1Results posted
• A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE-BRAVE II)CompletedNCT03616964Phase 3Results posted
• A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus ErythematosusTerminatedNCT03616912Phase 3Results posted
• A Study of Ustekinumab in Participants With Active Systemic Lupus ErythematosusTerminatedNCT03517722Phase 3Results posted
• Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Efavaleukin Alfa in Participants With Systemic Lupus ErythematosusCompletedNCT03451422Phase 1Results posted
• An Extension Study of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus ErythematosusTerminatedNCT03407482Phase 2Results posted
• A Study of KZR-616 in Patients With SLE With and Without Lupus NephritisCompletedNCT03393013Phase 1/2Results posted
• Study of BOS161721 in Systemic Lupus Erythematosus (SLE) Patients on a Background of Limited Standard of CareCompletedNCT03371251Phase 1/2Results posted
• BENLYSTA® Special Drug Use InvestigationCompletedNCT03370263Results posted
• Safety and Tolerability Study Of PF-06835375 In Subjects With Seropositive Systemic Lupus Erythematosus Or Rheumatoid ArthritisCompletedNCT03334851Phase 1Results posted
• A Study to Evaluate the Efficacy and Safety of Belimumab Administered in Combination With Rituximab to Adult Subjects With Systemic Lupus Erythematosus (SLE) - BLISS-BELIEVECompletedNCT03312907Phase 3Results posted
• Open-label Study of Tofacitinib for Moderate to Severe Skin Involvement in Young Adults With LupusCompletedNCT03288324Phase 1/2Results posted
• An Investigational Study to Evaluate BMS-986165 in Participants With Systemic Lupus ErythematosusCompletedNCT03252587Phase 2Results posted
• Acupressure for Fatigue in Systemic Lupus ErythematosusTerminatedNCT03200548Not applicableResults posted
• Aerobic Exercise in Women With Systemic Lupus ErythematosusTerminatedNCT03186794Not applicableResults posted
• A Study to Evaluate the Efficacy and Safety of CC-220 in Subjects With Active Systemic Lupus ErythematosusCompletedNCT03161483Phase 2Results posted
• Study to Evaluate Safety and Efficacy of Filgotinib and Lanraplenib in Females With Moderately-to-Severely Active Cutaneous Lupus Erythematosus (CLE)CompletedNCT03134222Phase 2Results posted
• Relevance of Monitoring Blood and Salivar Levels of Drugs Used in Rheumatic Autoimmune DiseasesCompletedNCT03122431Phase 4Results posted
• Exercise and Arterial Stiffness in Systemic Lupus ErythematosusCompletedNCT03107442Not applicableResults posted
• JBT-101 in Systemic Lupus Erythematosus (SLE)CompletedNCT03093402Phase 2Results posted
• Study of Anti-Malarials in Incomplete Lupus ErythematosusCompletedNCT03030118Phase 2Results posted
• Women Empowered to Live With Lupus StudyCompletedNCT02988661Not applicableResults posted
• A Phase II Study of M2951 in SLETerminatedNCT02975336Phase 2Results posted
• A Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Anifrolumab in Adult Type I Interferon Test High Systemic Lupus Erythematosus Subject With Active Skin ManifestationsCompletedNCT02962960Phase 2Results posted
• Acthar Gel for Active Systemic Lupus Erythematosus (SLE)CompletedNCT02953821Phase 4Results posted
• Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of GSK2646264 in Cutaneous Lupus Erythematosus SubjectsCompletedNCT02927457Phase 1Results posted
• Transcutaneous Vagus Nerve Stimulation for the Treatment of LupusTerminatedNCT02917265Phase 2Results posted
• A Study of the Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus ErythematosusCompletedNCT02908100Phase 2Results posted
• Belimumab Phase I Study in Chinese Subjects With Systemic Lupus ErythematosusCompletedNCT02880852Phase 1Results posted
• Study to Evaluate BIIB059 (Litifilimab) in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE)CompletedNCT02847598Phase 2Results posted
• Using the Cholinergic Anti-Inflammatory Pathway to Treat Systemic Lupus Musculoskeletal PainCompletedNCT02822989Not applicableResults posted
• A Phase 2 Efficacy and Safety Study of Dapirolizumab Pegol (DZP) in Systemic Lupus ErythematosusCompletedNCT02804763Phase 2Results posted
• Long Term Safety of Anifrolumab in Adult Subjects With Active Systemic Lupus ErythematosusCompletedNCT02794285Phase 3Results posted
• A Study of the Effect of XmAb®5871 in Patients With Systemic Lupus ErythematosusCompletedNCT02725515Phase 2Results posted
• A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus (SLE)CompletedNCT02708095Phase 2Results posted
• Phase IIb Study of IFN-K in Systemic Lupus ErythematosusTerminatedNCT02665364Phase 2Results posted
• A Phase 2a of RSLV-132 in Subjects With Systemic Lupus Erythematosus (SLE)CompletedNCT02660944Phase 2Results posted
• Single Ascending Dose Study of AMG 570 in Healthy SubjectsCompletedNCT02618967Phase 1Results posted
• OPAM-IA: Using Digital Activity Trackers to Improve Physical Activity in Inflammatory ArthritisCompletedNCT02554474Not applicableResults posted
• Proof-of-Concept Study With BT063 in Subjects With Systemic Lupus ErythematosusCompletedNCT02554019Phase 2Results posted
• Dose Ranging Study of Brentuximab Vedotin in Adults With LupusTerminatedNCT02533570Phase 2Results posted
• A 52-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus ErythematosusCompletedNCT02504645Phase 3Results posted
• Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of ACT-334441 in Subjects With Systemic Lupus ErythematosusCompletedNCT02472795Phase 1/2Results posted
• Efficacy and Safety of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus ErythematosusCompletedNCT02446912Phase 3Results posted
• Efficacy and Safety of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus ErythematosusCompletedNCT02446899Phase 3Results posted
• A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus ErythematosusCompletedNCT02437890Phase 2Results posted
• Abatacept for SLE Arthritis (IM101-330)TerminatedNCT02429934Phase 1/2Results posted
• Autologous Polyclonal Tregs for LupusTerminatedNCT02428309Phase 1Results posted
• Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint ProsthesisTerminatedNCT02408471Not applicableResults posted
• A Phase 2a, Efficacy and Safety Study of Ustekinumab in Systemic Lupus ErythematosusCompletedNCT02349061Phase 2Results posted
• Role of PPAR-y Agonists in Immunomodulation and Vascular Prevention in SLE (PPAR-SLE)CompletedNCT02338999Phase 1/2Results posted
• Individualized Patient Decision Making for Treatment Choices Among Minorities With LupusCompletedNCT02319525Not applicableResults posted
• Clarification of Abatacept Effects in SLE With Integrated Biologic and Clinical ApproachesCompletedNCT02270957Phase 2Results posted
• Safety and Efficacy Study of a Biologic to Treat Systemic Lupus ErythematosusCompletedNCT02265744Phase 2Results posted

← Lupus Erythematosus, Systemic overview